Samples of crocidolite (12001284), amosite (12172735), and Canadian chrysotile (12001295) were prepared by five different methods for intratracheal injection to rats. A fairly high mortality was noted in the first 6 months, generally from pneumonia. Of the 1537 rats injected intratracheally one to four times, only 727 rats survived 6 months. The total dosage ranged from 1.75 to 21 milligrams. The results of the study indicated that the intratracheal injection of the three most important asbestos (1332214) dusts into rats caused no induction of cancer. It made no difference to the outcome whether these dusts were natural or had been modified by the addition or subtraction of trace metals, or whether the dusts had been heated. A significant lessening of the fibrogenicity of asbestos dust was caused by heating the dusts. These findings suggested that the theory that trace metals assist in the pathogenic potential of asbestos dust must be abandoned. The failure of lung cancers to develop in this study as they had in previous studies could not be explained. The authors conclude that the pathogenicity of chrysotile asbestos may not be attributable to its fibrous shaped particles, its magnesium-silicate molecule, or to its crystalline character.
Links with this icon indicate that you are leaving the CDC website.
The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
You will be subject to the destination website's privacy policy when you follow the link.
CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website.
For more information on CDC's web notification policies, see Website Disclaimers.
CDC.gov Privacy Settings
We take your privacy seriously. You can review and change the way we collect information below.
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
Cookies used to make website functionality more relevant to you. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests.
Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data.
Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. These cookies may also be used for advertising purposes by these third parties.
Thank you for taking the time to confirm your preferences. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page.